BCL2 and glioblastoma: In addition, chemoresistance to temozolomide was associated with upregulation of miR-9 (targeting/patched homolog 1) in CD133-positive GBM cells and of Bcl-2-interacting mediator of cell death - targeting miR-138[75-77].